Kirsch Pharma
Kirsch Pharma GmbH is a German, owner-managed supplier of pharmaceutical raw materials — APIs, excipients, mineral salts and customised mixtures — serving pharmaceutical, biopharmaceutical, special nutrition and cosmetics manufacturers globally through owned subsidiaries and direct B2B sales.
- Company typePrivate
- Founded1980
- HeadquartersSalzgitter, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kirsch Pharma does
Kirsch Pharma GmbH is an independent, owner-managed German pharmaceutical raw materials supplier headquartered in Salzgitter, operating continuously since its founding in Isernhagen in 1980. The company supplies active pharmaceutical ingredients (APIs), excipients, mineral salts, amino acids, vitamins, and customised mixtures to four target verticals: pharmaceutical, biopharmaceutical, special nutrition (including infant and medical nutrition), and cosmetics. Its core technical capability is particle engineering, encompassing mixing, grinding, sieving, compacting and granulating, delivered through ready-to-use blends and a catalogue of more than 1,000 packaging and product combinations. The firm also operates a wholly-owned bio-pharmaceutical subsidiary (Kirsch BioPharm, founded 2015 in Wedemark) targeting higher-complexity bioprocessing inputs.
The business operates a B2B direct sales model with owned subsidiaries in Spain (Madrid/Barcelona), South Africa (Johannesburg), China (Shanghai), Singapore, and Australia (Sydney), plus sales coverage in France. Revenue is generated through quote-based one-time sales of raw materials and contracted processing services, with pricing not publicly disclosed. A multi-layered compliance stack — including DIN ISO 9001 (since 1995), ICH/EU GMP (since 2014), FSSC 22000, FDA inspection, Kosher, Halal, AEO and Sedex — underwrites qualification with regulated pharmaceutical buyers, and SAP-based documentation supports full lot traceability from raw material to finished packaged product.
Marketing and commercial engagement rely on a global sales team, the company website (German and English), and localised LinkedIn presences for each subsidiary. Within the input data there is no disclosed revenue, no headcount figure consistent with the named personnel, and no evidence of AI/ML capability or external investment; the company presents as a stable, self-funded specialty chemicals supplier pursuing steady geographic and product-surface expansion, most recently extending into complex biotechnology mixture platforms in 2025.
Kirsch Pharma firmographics
Firmographics- Name
- Kirsch Pharma
- Legal name
- Kirsch Pharma GmbH
- Website
- https://kirschpharma.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Kirsch Pharma GmbH is a German, owner-managed supplier of pharmaceutical raw materials — APIs, excipients, mineral salts and customised mixtures — serving pharmaceutical, biopharmaceutical, special nutrition and cosmetics manufacturers globally through owned subsidiaries and direct B2B sales.
- Ownership category
- akta.pro rank
Kirsch Pharma industry classification
Industry- Product category
- Pharmaceutical Raw Materials
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
- akta.pro secondary industries
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Full-Line Pharmaceutical Wholesalers (HLAIAJAA)
Keywords
Where Kirsch Pharma is headquartered
LocationHeadquarters
- HQ city
- Salzgitter
- HQ country
- Germany
- HQ region
- Europe
Offices8 records
Markets served
Kirsch Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Raw Materials Sales: B2B sale of pharmaceutical raw materials including APIs, excipients, mineral salts, amino acids, vitamins, and customized mixtures. Revenue generated through product sales to pharmaceutical, biotechnology, cosmetics, and nutrition industries.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Kirsch Pharma product offering
Product offeringCore offering
Kirsch Pharma manufactures and globally distributes premium-quality pharmaceutical raw materials — including APIs, excipients, mineral salts, amino acids, vitamins, saccharides, nucleotides, and tailored multi-component mixtures — for the pharmaceutical, biopharmaceutical, special nutrition, and cosmetics industries. The company complements its raw materials portfolio with particle engineering services (mixing, grinding, sieving, compacting, granulating), customized packaging in over 1,000 product-package combinations, and personalized pharma consulting under GMP, ISO 9001, and FDA-inspected quality systems.
Product overview
Kirsch Pharma is a German pharmaceutical raw materials supplier offering a comprehensive portfolio of products and services across four target segments: Pharma, Biopharma, Special Nutrition, and Cosmetics. The core product portfolio includes pharmaceutical raw materials (APIs, excipients, mineral salts, organic compounds), biopharmaceutical products (trace element salts, saccharides, amino acids, nucleotides, buffers), special nutrition products (saccharides, sweeteners, mineral mixes for infant and medical nutrition), and cosmetic ingredients (urea, talcum, mineral salts). Supporting the product portfolio, Kirsch Pharma provides manufacturing services including mixing, grinding/sieving, compacting/granulating, and complex mixture development for cell culture media. The company also offers customized packaging solutions with over 1000 product-packaging combinations and pharma consulting services. The company operates globally through subsidiaries in Spain, South Africa, China, Singapore, and Australia, plus the Kirsch BioPharm subsidiary for biopharmaceutical products.
Differentiator
Problem solved
Functional benefit
Brands
- Kirsch BioPharm: Biopharmaceutical raw materials and biotechnology solutions subsidiary of Kirsch Pharma
Products and services
- Pharmaceutical Raw Materials High-quality pharmaceutical raw materials including APIs, excipients, mineral salts, and organic compounds used by pharmaceutical manufacturers in infusion solutions, dialysis solutions, oral rehydration salts, tablets, and capsules.
- Biopharmaceutical Products Raw materials for biotechnological production including mineral salts of trace elements, saccharides, amino acids, choline salts, nucleotides, ammonium sulfate, urea for protein purification, formates for enzyme stabilization, and pH regulators/buffers.
- Special Nutrition Products Raw materials for infant nutrition, medical nutrition, and nutraceuticals including saccharides, sweeteners, nucleotides, and mineral mixes such as low-sodium salt blends.
- Cosmetic Ingredients High-purity ingredients for cosmetic and skincare products including urea, talcum, and organic and inorganic mineral salts for dermatological and dental applications.
- Mixing Services High-performance mixing service that produces ready-to-use blends applicable directly at customer facilities, reducing process steps, saving time, and ensuring consistent quality.
- Grinding & Sieving Services Controlled grinding and precision sieving service achieving uniform particle structure for good blendability, improved solubility, and reliable downstream processing.
- Compacting & Granulating Services Service transforming fine powders into free-flowing, dust-free products through compacting or granulation, enabling easier handling and higher dosing accuracy.
- Customized Packaging Solutions More than 1,000 different packaging and product combinations ranging from small packages to containers, including paper bags, chemical bottles, fiber drums, wide-neck drums, plastic buckets, Big Bags, and Curtec screw-top drums.
- Pharma Consulting Services Personalized consulting services for customized product modifications, manufacturing process optimization, and regulatory affairs support for pharmaceutical customers.
- Complex Mixture Development Customized formulations combining multiple individual components, such as cell culture media, that are technologically advanced and hygienically safe, aligned with specific customer requirements.
Quantifiable outcome
- More than 1,000 different packaging and product combinations available
- +2 more outcomes
Companies that use Kirsch Pharma
Customer profileSegments4 records
Ideal customer profiles4 records
Kirsch Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Kirsch Pharma partnerships and signals
Strategic signalScale indicators4 records
Recent moves16 records
Expansion highlights5 records
Kirsch Pharma competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Kirsch Pharma social profiles
Digital presenceKirsch Pharma compliance and trust
Trust signalCompliance9 records
Kirsch Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kirsch Pharma leadership team
Management profileNumber of profiles
Profiles13 records
Kirsch Pharma subsidiaries and ownership
Company hierarchySubsidiaries6 records
Kirsch Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kirsch Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kirsch Pharma
What does Kirsch Pharma do?
Kirsch Pharma manufactures and globally distributes premium-quality pharmaceutical raw materials — including APIs, excipients, mineral salts, amino acids, vitamins, saccharides, nucleotides, and tailored multi-component mixtures — for the pharmaceutical, biopharmaceutical, special nutrition, and cosmetics industries. The company complements its raw materials portfolio with particle engineering services (mixing, grinding, sieving, compacting, granulating), customized packaging in over 1,000 product-package combinations, and personalized pharma consulting under GMP, ISO 9001, and FDA-inspected quality systems.
Is Kirsch Pharma a public or private company?
Kirsch Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Kirsch Pharma founded?
Kirsch Pharma was founded in 1980. It employs 1 to 10 people.
Where is Kirsch Pharma based?
Kirsch Pharma is headquartered in Salzgitter, Germany, in the Europe region.
How does Kirsch Pharma make money?
One revenue line is on record: pharmaceutical Raw Materials Sales.
Does Kirsch Pharma have an API?
No public API is recorded for Kirsch Pharma.
What industry is Kirsch Pharma in?
Kirsch Pharma's product category is Pharmaceutical Raw Materials. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 3254 and its SIC code is 5122.